At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ASND Ascendis Pharma A/S
Trading 05-20 10:40:58 EDT
121.21
+0.09
+0.07%
High122.13
Low121.02
Vol25.86K
Open121.02
D1 Closing121.12
Amplitude0.92%
Mkt Cap6.95B
Tradable Cap6.90B
Total Shares57.35M
T/O3.14M
T/O Rate0.05%
Tradable Shares56.89M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Ascendis Pharma Expands Capital with Warrants and Shares
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/? for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.